<?xml version="1.0" encoding="UTF-8"?>
<p class="p">While rbST is banned in the European Union, Canada, Japan, Australia, and New Zealand [
 <xref rid="B10-animals-05-00361" ref-type="bibr" class="xref">10</xref>], the drug is approved in the United States, despite substantial controversy. One of the primary welfare concerns associated with the increased milk production caused by rbST is the potential risk for mastitis. Some of the initial studies on rbST indicated that its use was linked to an increase (for example, Burton 
 <italic class="italic">et al</italic>., 1990 [
 <xref rid="B123-animals-05-00361" ref-type="bibr" class="xref">123</xref>] and Pell 
 <italic class="italic">et al</italic>., 1992 [
 <xref rid="B124-animals-05-00361" ref-type="bibr" class="xref">124</xref>], but see White 
 <italic class="italic">et al</italic>., 1994 [
 <xref rid="B53-animals-05-00361" ref-type="bibr" class="xref">53</xref>] for counter examples).
</p>
